Evidence map›Paper›PMID 40390206›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Regular use of opioids and dementia, cognitive measures, and neuroimaging outcomes among UK Biobank participants with chronic non-cancer pain.

Tengfei Lin, Jed A Barash, Shiyu Wang, Fuxiao Li, Zhirong Yang, W Andrew Kofke, Feng Sha, Jinling Tang

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tengfei LinShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China.ORCID 0000-0001-5282-6945
Jed A BarashDepartment of Medicine, Veterans Home, Chelsea, Massachusetts, USA.
Shiyu WangShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China.
Fuxiao LiDepartment of Computational Biology and Medical Big Data, Shenzhen University of Advanced Technology, Shenzhen, Guangdong Province, China.
Zhirong YangShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China.
W Andrew KofkeDepartment of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Feng ShaShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China.ORCID 0000-0002-0966-5733
Jinling TangShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China.

Funding

National Natural Science Foundation of China 72304267NIH HHS 1R21DA051737-01A1Shenzhen Science and Technology Program KQTD20190929172835662
6 · The paper itself

Abstract

introductionWe investigated the association between regular opioid use and incident dementia, neuroimaging outcomes, and cognitive measures.

methodsCox regression was used to assess the association between opioid use and incident dementia among197,673 UK Biobank participants with chronic non-cancer pain. Linear and logistic regression were applied to explore the associations between opioid use and dementia-related neuroimaging and cognitive function outcomes.

resultsRegular opioid use was associated with a 20% higher risk of all-cause dementia and a 49% higher risk of vascular dementia (VD) compared with those not using analgesics. Moreover, those using strong opioids had a 72% higher risk of all-cause dementia and a 155% higher risk of VD. Strong opioid use was also linked to reductions in hippocampal, white matter, and total brain volumes. Lastly, regular opioid use was associated with lower fluid intelligence. DISCUSSION: A higher risk of dementia was observed among participants regularly using opioids, escalating with opioid strength. HIGHLIGHTS: Regular opioid use was associated with an increased risk of all-cause dementia and VD. Those using strong opioids had a much higher risk of all-cause dementia and VD. Strong opioid use was also associated with worse neuroimaging outcomes. Regular opioid use was also associated with lower fluid intelligence.

Indexed as

Analgesics, OpioidChronic PainCognitionDementiaAgedBiological Specimen BanksBrainFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeuroimagingNeuropsychological TestsRisk FactorsUK BiobankAnalgesics, Opioidcognitive functiondementianeuroimagingopioidUK Biobank

Identifiers

PMID40390206
PMCPMC12089068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.